Victorian young technology entrepreneur challenge


Thursday, 08 August, 2013

Small tech company incubator the Small Technologies Cluster (STC) has launched ‘MedTech’s Got Talent’, a Victorian-wide challenge focused on training and supporting emerging medical technology students and recent graduate entrepreneurs.

The aim of the program is to develop a more entrepreneurial culture and to grow Victoria’s medical technology cluster. The program will do this by helping young entrepreneurs develop and refine their skills in pitching a business concept, developing a technology roadmap and launching commercialisation activities for enabling medical technology innovations.

Those eligible to apply include currently registered students, currently employed postdocs or recent graduates (<5 years) in Victoria who are involved in a technology or service related to medical devices, diagnostics or health IT.

The top 30 applicants will be selected to participate in a Rapid Fire Round (on 31 October) where eight product development mentors each select two teams, resulting in 16 semifinalists, to mentor intensively through a one-month training program leading up to The Finals pitch event.

At The Finals, each team will have 3 minutes to pitch their business concepts, after which five category winners will be announced. The five winning teams will receive a $20,000 voucher to undertake an intensive three-month accelerated technology road-mapping with their mentors along with support from Victoria’s enabling technology sponsors based in STC’s ‘The Tap’ advanced technology coworking space.

After the three-month intensive, the five teams will pitch to real investors in a closed-door investor boardroom event.

An executive summary of a business concept needs to be submitted by 22 October. If you don’t have an idea of your own but want to get involved, you can join a team - contact STC for details.

For more information, contact Laura Faulconer or go to the STC website.

Related News

Cancer drug eliminates bone metastasis in lab models

Researchers have developed a novel treatment that is specific to breast cancer bone metastasis...

TGA rejects Alzheimer's drug due to safety concerns

The TGA determined that the demonstrated efficacy of lecanemab in treating Alzheimer's did...

Defective sperm doubles pre-eclampsia risk in IVF patients

A high proportion of the father's spermatozoa possessing DNA strand breaks is associated with...


  • All content Copyright © 2024 Westwick-Farrow Pty Ltd